FEED the BULL

Welcome to Feed the Bull - A home for investment information and interaction.

Tag: Global Litigation

Sort
E.g., 2013-05-19
E.g., 2013-05-19
Enter a comma separated list of user names.

Coca-Cola Enterprises Inc. (NYSE:CCE) recently reported that the U.S. Federal Trade Commission and Canadian Competition Bureau have both cleared the Company’s proposed acquisition of the North American operations of Coca-Cola Enterprises, subject to certain firewall protective measures with respect to its new distribution agreements with Dr Pepper Snapple Group .

Proteonomix, Inc. (PROT.OB) recently reported further developments with its Joint Venture Company, XGEN Medical LLC (”XGen”) towards implementing operations in the United Arab Emirates.

Proteonomix, Inc. (PROT.OB) is a biotechnology company focused on developing therapeutics based upon the use of human cells and their derivatives.

PROT recently reported further developments with its Joint Venture Company, XGEN Medical LLC (”XGen”) towards implementing operations in the United Arab Emirates.

Proteonomix, Inc. (PROT.OB) is a biotechnology company focused on developing therapeutics based upon the use of human cells and their derivatives.

PROT recently reported further developments with its Joint Venture Company, XGEN Medical LLC (”XGen”) towards implementing operations in the United Arab Emirates.

Proteonomix, Inc. (PROT.OB) is a biotechnology company focused on developing therapeutics based upon the use of human cells and their derivatives.

PROT recently reported further developments with its Joint Venture Company, XGEN Medical LLC (”XGen”) towards implementing operations in the United Arab Emirates.

Proteonomix, Inc. (PROT.OB) recently reported further developments with its Joint Venture Company, XGEN Medical LLC (”XGen”) towards implementing operations in the United Arab Emirates.

Proteonomix, Inc. (PROT.OB) is a biotechnology company focused on developing therapeutics based upon the use of human cells and their derivatives. Proteoderm, Inc. is a wholly owned subsidiary of Proteonomix that has recently opened its retail web site, http://www.proteoderm.com, and begun accepting pre-orders for its anti-aging line of skin care products.

Castle Brands Inc. (AMEX:ROX) recently reported financial results for the three months ended June 30, 2010. In the fiscal 2011 first quarter, the Company had net sales of $6.1 million, a 4.4% increase from the prior year period. Net loss from operations was $1.7 million for the three months ended June 30, 2010, an improvement of 11.3% from $2.0 million for the comparable fiscal 2010 period.

Pages

ADVERTISE WITH US